Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 16/20 | 0.37 |
| ▸ | JAK2 | O60674 | 11/20 | 0.37 |
| ▸ | TYK2 | P29597 | 11/20 | 0.37 |
| ▸ | JAK3 | P52333 | 11/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2225926 | 0.91 | JAK1 (0.40) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2278143 | 0.90 | JAK1 (0.40) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2274403 | 0.89 | JAK1 (0.37) | JAK1JAK2TYK2JAK3CYP2C19 | |
| SCHEMBL2226056 | 0.85 | HTR6 (0.31) | JAK1JAK2TYK2JAK3CYP2C19 | |
| SCHEMBL2272557 | 0.85 | JAK1 (0.35) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2278163 | 0.85 | JAK1 (0.39) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2273730 | 0.80 | JAK1 (0.41) | JAK1JAK2TYK2JAK3CYP2C19 | |
| SCHEMBL2271087 | 0.76 | JAK1 (0.45) | JAK1JAK2TYK2JAK3CYP2C19 | |
| SCHEMBL2228322 | 0.76 | JAK1 (0.52) | JAK1JAK2TYK2JAK3CYP2C19 | |
| SCHEMBL2223564 | 0.76 | JAK1 (0.41) | JAK1JAK2TYK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |